Delay to Adjuvant Chemotherapy: Survival and Recurrence in Patients of Rectal Cancer Treated with Neo-adjuvant Chemoradiotherapy and Surgery.
Da Wei ThongJason KimArun NaikCu Tai LuGregory John NolanMicheal Von PapenPublished in: Journal of gastrointestinal cancer (2021)
This study has demonstrated delaying a patient to adjuvant ChT will lower their DFS and increase their HR compared with those whose treatment is not delayed. We have long been too focused on local control; hence, priority needs to be shifted to efforts in managing potential distant disease in a timely manner.
Keyphrases
- rectal cancer
- end stage renal disease
- newly diagnosed
- early stage
- locally advanced
- ejection fraction
- minimally invasive
- chronic kidney disease
- lymph node
- prognostic factors
- peritoneal dialysis
- case report
- coronary artery bypass
- human health
- coronary artery disease
- climate change
- combination therapy
- percutaneous coronary intervention
- smoking cessation
- atrial fibrillation